# Cyclobenzaprine HCL ER

NDC: 72189-362
Generic name: Cyclobenzaprine HCL ER
Labeler / Manufacturer: Direct_Rx
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20220725

FDA application: NDA021777

## Active ingredients

- CYCLOBENZAPRINE HYDROCHLORIDE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72189-362"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72189-362
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e4a3383a-7b30-25b7-e053-2995a90a341b